Delta Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5K Hold
90
﹤0.01% 419
2025
Q4
$11K Hold
90
﹤0.01% 430
2025
Q3
$9.99K Sell
90
-5
-5% -$568 ﹤0.01% 438
2025
Q2
$10.5K Hold
95
﹤0.01% 431
2025
Q1
$10.6K Buy
+95
New +$9.8K ﹤0.01% 423
2017
Q1
Sell
-75
Closed -$5K 627
2016
Q4
$5K Buy
+75
New +$5.58K ﹤0.01% 501
2016
Q3
Sell
-102
Closed -$9K 580
2016
Q2
$9K Buy
102
+1
+1% +$89 ﹤0.01% 420
2016
Q1
$9K Hold
101
﹤0.01% 419
2015
Q4
$10K Buy
101
+1
+1% +$104 ﹤0.01% 405
2015
Q3
$10K Hold
100
﹤0.01% 404
2015
Q2
$12K Buy
+100
New +$10.9K ﹤0.01% 395

Other funds holding GILD

Delta Asset Management's GILD Position: Q1 2026 in Review

Delta Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 90 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Delta Asset Management first reported a position in GILD in Q2 2015 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Delta Asset Management held 90 shares of Gilead Sciences worth $12.5K as of Q1 2026.
  • Delta Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Delta Asset Management's portfolio in Q1 2026, its #419 holding.
  • Delta Asset Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.